ArticleEuropean journal of clinical pharmacology2022

A view of response and resistance to atomoxetine treatment in children with ADHD: effects of CYP2C19 polymorphisms and BDNF levels.

Esra Demirci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.